These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25964945)

  • 41. Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan.
    Igarashi A; Akazawa M; Murata T; Taguchi T; Sadosky A; Ebata N; Willke R; Fujii K; Doherty J; Kobayashi M
    Clinicoecon Outcomes Res; 2015; 7():505-20. PubMed ID: 26504403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness analysis for a tele-based health coaching program for chronic disease in primary care.
    Oksman E; Linna M; Hörhammer I; Lammintakanen J; Talja M
    BMC Health Serv Res; 2017 Feb; 17(1):138. PubMed ID: 28202032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors Supporting Implementation among CDSMP Organizations.
    Paone D
    Front Public Health; 2014; 2():237. PubMed ID: 25964928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decision aids for patients considering total joint replacement: a cost-effectiveness analysis alongside a randomised controlled trial.
    Trenaman L; Stacey D; Bryan S; Taljaard M; Hawker G; Dervin G; Tugwell P; Bansback N
    Osteoarthritis Cartilage; 2017 Oct; 25(10):1615-1622. PubMed ID: 28624294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program.
    Bourbeau J; Granados D; Roze S; Durand-Zaleski I; Casan P; Köhler D; Tognella S; Viejo JL; Dal Negro RW; Kessler R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():645-657. PubMed ID: 30936689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE program.
    Jódar-Sánchez F; Malet-Larrea A; Martín JJ; García-Mochón L; López Del Amo MP; Martínez-Martínez F; Gastelurrutia-Garralda MA; García-Cárdenas V; Sabater-Hernández D; Sáez-Benito L; Benrimoj SI
    Pharmacoeconomics; 2015 Jun; 33(6):599-610. PubMed ID: 25774017
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-Effectiveness Evaluation of Collaborative Care for Diabetes and Depression in Primary Care.
    Johnson JA; Lier DA; Soprovich A; Al Sayah F; Qiu W; Majumdar SR
    Am J Prev Med; 2016 Jul; 51(1):e13-20. PubMed ID: 26947212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An economic evaluation of an augmented cognitive behavioural intervention vs. computerized cognitive training for post-stroke depressive symptoms.
    van Eeden M; Kootker JA; Evers SM; van Heugten CM; Geurts AC; van Mastrigt GA
    BMC Neurol; 2015 Dec; 15():266. PubMed ID: 26715040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-acute care for older people in community hospitals--a cost-effectiveness analysis within a multi-centre randomised controlled trial.
    O'Reilly J; Lowson K; Green J; Young JB; Forster A
    Age Ageing; 2008 Sep; 37(5):513-20. PubMed ID: 18515290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic Disease Self-Management Program in American Sign Language: Evaluation and Recommendations.
    Havercamp SM; Gjessing R; Whalen Smith CN
    Health Promot Pract; 2020 Mar; 21(2):259-267. PubMed ID: 30132380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic disease self-management program for low back pain in the elderly.
    Haas M; Groupp E; Muench J; Kraemer D; Brummel-Smith K; Sharma R; Ganger B; Attwood M; Fairweather A
    J Manipulative Physiol Ther; 2005 May; 28(4):228-37. PubMed ID: 15883575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost effectiveness of the Expert Patients Programme (EPP) for patients with chronic conditions.
    Richardson G; Kennedy A; Reeves D; Bower P; Lee V; Middleton E; Gardner C; Gately C; Rogers A
    J Epidemiol Community Health; 2008 Apr; 62(4):361-7. PubMed ID: 18339831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Six-Month and One-Year Outcome of a Chronic Disease Self-Management Program Among Older Adults in Macao: A Quasi-Experimental Study.
    Leong SM; Lei WI; Chan UW
    SAGE Open Nurs; 2020; 6():2377960820958231. PubMed ID: 35155758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of a chronic disease self-management program on healthcare utilization in eastern Ontario, Canada.
    Liddy C; Johnston S; Guilcher S; Irving H; Hogel M; Jaglal S
    Prev Med Rep; 2015; 2():586-90. PubMed ID: 26844122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Participation of lower-to-middle wage workers in a study of Chronic Disease Self-Management Program (CDSMP) effectiveness: Implications for reducing chronic disease burden among racial and ethnic minority populations.
    Kneipp SM; Horrell L; Gonzales C; Linnan L; Lee Smith M; Brady T; Trogdon JG
    Public Health Nurs; 2019 Sep; 36(5):591-602. PubMed ID: 31168851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of session zero in successful completion of chronic disease self-management program workshops.
    Jiang L; Smith ML; Chen S; Ahn S; Kulinski KP; Lorig K; Ory MG
    Front Public Health; 2014; 2():205. PubMed ID: 25964918
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigating the impact of a chronic disease self-management programme on depression and quality of life scores in an Irish sample.
    Campbell D; Wilson O'Raghallaigh J; O'Doherty V; Lunt V; Lowry D; Mulhern S; Lonergan K; McSharry K; Lynnott J; Forry M; Evans D; Pardoe P; Ward H; Hevey D
    Psychol Health Med; 2022 Aug; 27(7):1609-1617. PubMed ID: 33902360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Promotion of self-management in vulnerable older people: a narrative literature review of outcomes of the Chronic Disease Self-Management Program (CDSMP).
    Jonker AA; Comijs HC; Knipscheer KC; Deeg DJ
    Eur J Ageing; 2009 Dec; 6(4):303-314. PubMed ID: 19920862
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attending with family members, completion rate and benefits accrued from chronic disease self-management program.
    Shi J; Ferretti L; McCallion P
    Chronic Illn; 2022 Dec; 18(4):784-795. PubMed ID: 34282954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of the chronic disease self-management program (CDSMP) on self-perceived frailty condition: the EU-EFFICHRONIC project.
    Zora S; Custodero C; Pers YM; Valsecchi V; Cella A; Ferri A; Pisano-González MM; Peñacoba Maestre D; Vazquez Alvarez R; Raat H; Baker G; Pilotto A
    Ther Adv Chronic Dis; 2021; 12():20406223211056722. PubMed ID: 34820081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.